Walgreens Boots Alliance, Inc. (WBA)
NASDAQ: WBA · IEX Real-Time Price · USD
17.34
-0.39 (-2.20%)
At close: May 1, 2024, 4:00 PM
17.37
+0.03 (0.17%)
After-hours: May 1, 2024, 6:01 PM EDT
Walgreens Boots Alliance Revenue
Walgreens Boots Alliance had revenue of $144.60B in the twelve months ending February 29, 2024, with 8.48% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $37.05B with 6.28% year-over-year growth. In the fiscal year ending August 31, 2023, Walgreens Boots Alliance had annual revenue of $139.08B with 4.81% growth.
Revenue (ttm)
$144.60B
Revenue Growth
+8.48%
P/S Ratio
0.10
Revenue / Employee
$436,846
Employees
331,000
Market Cap
14.96B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Aug 31, 2023 | 139.08B | 6.38B | 4.81% |
Aug 31, 2022 | 132.70B | 194.00M | 0.15% |
Aug 31, 2021 | 132.51B | 10.53B | 8.63% |
Aug 31, 2020 | 121.98B | 1.91B | 1.59% |
Aug 31, 2019 | 120.07B | -11.46B | -8.71% |
Aug 31, 2018 | 131.54B | 13.32B | 11.27% |
Aug 31, 2017 | 118.21B | 863.00M | 0.74% |
Aug 31, 2016 | 117.35B | 13.91B | 13.44% |
Aug 31, 2015 | 103.44B | 27.05B | 35.41% |
Aug 31, 2014 | 76.39B | 4.18B | 5.78% |
Aug 31, 2013 | 72.22B | 584.00M | 0.82% |
Aug 31, 2012 | 71.63B | -551.00M | -0.76% |
Aug 31, 2011 | 72.18B | 4.76B | 7.07% |
Aug 31, 2010 | 67.42B | 4.09B | 6.45% |
Aug 31, 2009 | 63.34B | 4.30B | 7.29% |
Aug 31, 2008 | 59.03B | 5.27B | 9.81% |
Aug 31, 2007 | 53.76B | 6.35B | 13.40% |
Aug 31, 2006 | 47.41B | 5.21B | 12.34% |
Aug 31, 2005 | 42.20B | 4.69B | 12.51% |
Aug 31, 2004 | 37.51B | 5.00B | 15.39% |
Aug 31, 2003 | 32.51B | 3.82B | 13.33% |
Aug 31, 2002 | 28.68B | 4.06B | 16.48% |
Aug 31, 2001 | 24.62B | 3.42B | 16.11% |
Aug 31, 2000 | 21.21B | 3.37B | 18.88% |
Aug 31, 1999 | 17.84B | 2.53B | 16.54% |
Aug 31, 1998 | 15.31B | 1.94B | 14.54% |
Aug 31, 1997 | 13.36B | 1.59B | 13.46% |
Aug 31, 1996 | 11.78B | 1.38B | 13.30% |
Aug 31, 1995 | 10.40B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical | 15.85B |
Viatris | 15.43B |
Laboratory Corporation of America Holdings | 12.16B |
Quest Diagnostics | 9.29B |
The Cooper Companies | 3.67B |
Revvity | 2.75B |
BioMarin Pharmaceutical | 2.47B |
BeiGene | 2.46B |
WBA News
- 4 hours ago - Walmart is closing down its health centers. What's that mean for Amazon, Walgreens and CVS? - Market Watch
- 8 hours ago - Walgreens stock price forecast: is it too cheap or a value trap? - Invezz
- 17 hours ago - As Their Clinics Sputter, Walgreens And Walmart Invest More In Specialty Pharmacy - Forbes
- 2 days ago - Walgreens' Next Frontier: Complex Conditions & Cell And Gene Therapy - Forbes
- 6 days ago - Walgreens Boots Alliance Declares Quarterly Dividend - Business Wire
- 6 days ago - Walgreens To Launch $24 Billion Business Dedicated To Specialty Pharmacy - Forbes
- 6 days ago - Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services - CNBC
- 6 days ago - Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business - Business Wire